CDY5P

Q-omics provides the consensus-scored CDY5P profile across patient tissues and cancer cell-line models. CDY5P expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in ESCA. Additionally, CDY5P RNA expression shows 499 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight ESCA, and STAD as cancer lineages where CDY5P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes CDY5P survival associations across molecular data types. CDY5P RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

CDY5P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	ESCA (54)	view →

This table ranks reproducible CDY5P RNA expression–survival associations across cancer types. High CDY5P expression shows unfavorable associations in ESCA. The ESCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify ESCA as the clearest survival context for CDY5P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.198	0.872	.003	54	view →

Pink = unfavorable, green = favorable. all 1 lineages →

CDY5P-ESCA (OS)

Explore this curve interactively →